Together, the present data illustrate the capacity for HIV-1 Tat to cause GR insensitivity (elevating basal circulating corticosterone levels) and promoting adrenal insufficiency in response to HPA activation to a natural or pharmacological challenge. The gene discussed is NR3C1; the disease is Adrenal insufficiency.